Experienced in Progressive Supranuclear Palsy

Dr. Michele Tagliati

Neurology
Cedars-Sinai Medical Center
8700 Beverly Blvd, 
West Hollywood, CA 
Offers Telehealth
Experienced in Progressive Supranuclear Palsy
Cedars-Sinai Medical Center
8700 Beverly Blvd, 
West Hollywood, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Michele Tagliati is a Neurologist in West Hollywood, California. Dr. Tagliati is rated as an Experienced provider by MediFind in the treatment of Progressive Supranuclear Palsy. His top areas of expertise are Movement Disorders, Parkinson's Disease, Drug Induced Dyskinesia, Essential Tremor, and Deep Brain Stimulation.

His clinical research consists of co-authoring 58 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Neurology
Licenses
Psychiatry & Neurology in NY
Hospital Affiliations
Cedars-Sinai Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health Group
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

CEDARS-SINAI MEDICAL CENTER
8700 Beverly Blvd, West Hollywood, CA 90048

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

The Effect of Adrenergic Blocker Therapy on Cardiac and Striatal Transporter Uptake in Pre-Motor and Symptomatic Parkinson's Disease
The Effect of Adrenergic Blocker Therapy on Cardiac and Striatal Transporter Uptake in Pre-Motor and Symptomatic Parkinson's Disease
Enrollment Status: Active_not_recruiting
Publish Date: January 28, 2025
Intervention Type: Drug
Study Drug: Carvedilol
Study Phase: Phase 2
A Randomized, Double-blind, Placebo-Controlled, 2-Period Crossover, Phase 2 Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral TAK-071 in Parkinson Disease Patients With Cognitive Impairment and an Elevated Risk of Falls
A Randomized, Double-blind, Placebo-Controlled, 2-Period Crossover, Phase 2 Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral TAK-071 in Parkinson Disease Patients With Cognitive Impairment and an Elevated Risk of Falls
Enrollment Status: Completed
Publish Date: May 14, 2024
Intervention Type: Drug
Study Drug: TAK-071
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study, With an Active-Treatment Dose-Blinded Period, to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Subjects With Parkinson's Disease
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study, With an Active-Treatment Dose-Blinded Period, to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Subjects With Parkinson's Disease
Enrollment Status: Terminated
Publish Date: February 28, 2022
Intervention Type: Drug
Study Drug: BIIB054
Study Phase: Phase 2
View 2 Less Clinical Trials

60 Total Publications

Adrenergic blockers, statins, and non-steroidal anti-inflammatory drugs are associated with later age at onset in Parkinson's disease.
Adrenergic blockers, statins, and non-steroidal anti-inflammatory drugs are associated with later age at onset in Parkinson's disease.
Journal: Journal of neurology
Published: October 24, 2024
Similar Doctors
Elite in Progressive Supranuclear Palsy
Dr. Daniel H. Geschwind
Neurology
Elite in Progressive Supranuclear Palsy
Dr. Daniel H. Geschwind
Neurology
300 Medical Plz, Suite B200, 
Los Angeles, CA 
 (3.8 miles away)
310-794-1195
Languages Spoken:
English

Daniel Geschwind is a Neurologist in Los Angeles, California. Dr. Geschwind is rated as an Elite provider by MediFind in the treatment of Progressive Supranuclear Palsy. His top areas of expertise are Autism Spectrum Disorder, Frontotemporal Dementia, Progressive Supranuclear Palsy, and Progressive Supranuclear Palsy Atypical.

Distinguished in Progressive Supranuclear Palsy
Dr. Yvette M. Bordelon
Neurology
Distinguished in Progressive Supranuclear Palsy
Dr. Yvette M. Bordelon
Neurology

Cedars-Sinai Medical Center

8700 Beverly Blvd, 
West Hollywood, CA 
 (0.1 miles away)
310-423-3277
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Yvette Bordelon is a Neurologist in West Hollywood, California. Dr. Bordelon is rated as a Distinguished provider by MediFind in the treatment of Progressive Supranuclear Palsy. Her top areas of expertise are Movement Disorders, Parkinson's Disease, Supranuclear Ophthalmoplegia, Thalamotomy, and Deep Brain Stimulation.

Distinguished in Progressive Supranuclear Palsy
Dr. Timothy S. Chang
Neurology
Distinguished in Progressive Supranuclear Palsy
Dr. Timothy S. Chang
Neurology

The Regents Of The University Of California

300 Medical Plz, 
Los Angeles, CA 
 (3.8 miles away)
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Timothy Chang is a Neurologist in Los Angeles, California. Dr. Chang is rated as a Distinguished provider by MediFind in the treatment of Progressive Supranuclear Palsy. His top areas of expertise are Supranuclear Ophthalmoplegia, Progressive Supranuclear Palsy Atypical, Progressive Supranuclear Palsy, and Brown Syndrome.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Tagliati's expertise for a condition
ConditionClose
View All 7 Distinguished Conditions
View All 12 Advanced Conditions
View All 38 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile